Tissue Engineering Strategies encompass a variety of innovative approaches aimed at creating functional biological substitutes to restore, repair, or replace damaged or diseased tissues. These strategies typically involve the convergence of cells, biomaterials, and signaling molecules to create three-dimensional constructs that mimic the native tissue architecture. One common approach is the use of scaffolds, which provide structural support for cell attachment, proliferation, and differentiation. These scaffolds can be made from natural or synthetic materials, offering a framework for tissue regeneration. Another key strategy involves the use of cells, such as stem cells or differentiated cells, to populate the scaffold and drive tissue formation. Advances in stem cell research have significantly contributed to the development of more robust tissue engineering solutions. Additionally, the incorporation of growth factors, cytokines, and other bioactive molecules into the engineered constructs helps orchestrate cellular behavior and enhance tissue regeneration. Bioprinting technologies have emerged as a cutting-edge strategy, allowing precise layer-by-layer deposition of cells and biomaterials to create complex tissue structures. Tissue engineering strategies are applied across various medical fields, including orthopedics, cardiology, dermatology, and neurology. Continuous research efforts focus on refining these strategies to improve clinical outcomes, enhance biocompatibility, and address specific challenges associated with different tissues and organs. The evolution of tissue engineering continues to play a pivotal role in advancing regenerative medicine and personalized therapeutic interventions.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States